(Q33763307)

29 July 2017

title

Delivery of peptide and non-peptide drugs through the respiratory tract (English)

1 reference

29 July 2017

Davis SS

1

1 reference

29 July 2017

publication date

1 November 1999

1 reference

Pharmaceutical science & technology today

29 July 2017

published in

1 reference

29 July 2017

volume

2

1 reference

29 July 2017

issue

11

1 reference

29 July 2017

page(s)

450-456

1 reference

Pharmacokinetic profile of alniditan nasal spray during and outside migraine attacks

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Evaluation of the clearance characteristics of bioadhesive systems in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Nasal physiology: neurochemical receptors, nasal cycle, and ciliary action

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Bioadhesive microspheres as a potential nasal drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

c-FOS-like immunoreactivity in rat brainstem neurons following noxious chemical stimulation of the nasal mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Chitosan as a novel nasal delivery system for peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Nasal Absorption of Propranolol in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Nasal delivery. The use of animal models to predict performance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Intranasal absorption of granulocyte-colony stimulating factor (G-CSF) from powder formulations, in sheep

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

Intranasal Administration of Insulin With Phospholipid as Absorption Enhancer: Pharmacokinetics in Normal Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

The AERX aerosol delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900199-6

7 January 2021

10.1016/S1461-5347(99)00199-6

Identifiers

DOI

1 reference

29 July 2017

1 reference